|
|||
|
|||
|
Advertisement
|
|
Advertisement
|
Topics are automatically created in this forum from a mix of newsfeeds. Please be aware that we have no control over the quality or factual representation of these postings. Some may be informational, whereas some may be wholly inaccurate.
Always research all options and discuss them with your physician before following any specific directive provided in these articles.
To aid other readers, you may rate each article as you review them.
Unfortunately, we have no control over duplicate postings which represent multiple sources of the same article.
Current feeds are: Google, IBS.about.com, Medical News Today, MedicineNet, Pubmed, SmartBrief, Yahoo
![]() ![]() |
Nov 6 2009, 08:42 AM
Post
#1
|
|||
|
Newsfeeder ![]() ![]() ![]() ![]() Posts: 13,124 Joined: 12-February 08 |
Bacterial infections: new and emerging enteric pathogens. Curr Opin Gastroenterol. 2009 Nov 2; Authors: Sherman PM, Ossa JC, Wine E PURPOSE OF REVIEW: The aim of this review is to highlight recent advances in knowledge of bacterial enteric infections. We focus on understanding of enterohemorrhagic Escherichia coli O157:H7 and Campylobacter jejuni infections, and to link these acute events with long-term consequences in a susceptible host, including irritable bowel syndrome and chronic inflammatory bowel diseases. RECENT FINDINGS: Enterohemorrhagic E. coli and C. jejuni are zoonotic infections that are acquired from exposure to tainted food (undercooked hamburger and chicken, respectively) and contaminated drinking water. Noninvasive E. coli O157:H7 elaborates Shiga-like toxins and protein effectors that are injected, via a molecular syringe that is encoded by a bacterial type 3 secretion system, into infected eukaryotic cells. Less is known about the precise virulence properties of enteroinvasive Campylobacter strains, but both enteric pathogens are able to disrupt polarized epithelial monolayers resulting in increased uptake of macromolecules and antigens. SUMMARY: An improved understanding of the epidemiology, pathobiology and mechanisms underlying infectious enterocolitides will provide the basis for developing new intervention strategies including, for example, the use of probiotics, to interrupt the infectious process. PMID: 19887937 [PubMed - as supplied by publisher] View the full article |
||
|
|
|||
![]() ![]() |
|
Lo-Fi Version | Time is now: 20th November 2009 - 06:11 PM |
| | We comply with the HONcode standard for trustworthy health information: verify here. |